JP2021508496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508496A5 JP2021508496A5 JP2020555291A JP2020555291A JP2021508496A5 JP 2021508496 A5 JP2021508496 A5 JP 2021508496A5 JP 2020555291 A JP2020555291 A JP 2020555291A JP 2020555291 A JP2020555291 A JP 2020555291A JP 2021508496 A5 JP2021508496 A5 JP 2021508496A5
- Authority
- JP
- Japan
- Prior art keywords
- lactis strain
- lactis
- locus
- kllac4
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023132434A JP2023166412A (ja) | 2017-12-27 | 2023-08-16 | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102017012109.5 | 2017-12-27 | ||
| DE102017012109.5A DE102017012109A1 (de) | 2017-12-27 | 2017-12-27 | Optimiertes Wirts-/Vektorsystem zur Erzeugung protektiver mono- und multivalenter subunit-Vakzine auf Basis der Hefe Kluyveromyces lactis |
| PCT/DE2018/000379 WO2019129321A2 (de) | 2017-12-27 | 2018-12-19 | Optimiertes wirts-/vektorsystem zur erzeugung protektiver mono- und multivalenter subunit-vakzine auf basis der hefe kluyveromyces lactis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023132434A Division JP2023166412A (ja) | 2017-12-27 | 2023-08-16 | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508496A JP2021508496A (ja) | 2021-03-11 |
| JP2021508496A5 true JP2021508496A5 (enExample) | 2022-01-06 |
| JP7782951B2 JP7782951B2 (ja) | 2025-12-09 |
Family
ID=65817691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555291A Active JP7782951B2 (ja) | 2017-12-27 | 2018-12-19 | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム |
| JP2023132434A Pending JP2023166412A (ja) | 2017-12-27 | 2023-08-16 | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023132434A Pending JP2023166412A (ja) | 2017-12-27 | 2023-08-16 | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11905517B2 (enExample) |
| EP (1) | EP3732293B1 (enExample) |
| JP (2) | JP7782951B2 (enExample) |
| KR (1) | KR102704217B1 (enExample) |
| CN (1) | CN111801422B (enExample) |
| BR (1) | BR112020013245A2 (enExample) |
| CA (1) | CA3086598A1 (enExample) |
| DE (2) | DE102017012109A1 (enExample) |
| DK (1) | DK3732293T3 (enExample) |
| EA (1) | EA202091435A1 (enExample) |
| ES (1) | ES2990197T3 (enExample) |
| HR (1) | HRP20241297T1 (enExample) |
| HU (1) | HUE068358T2 (enExample) |
| MX (1) | MX2020006846A (enExample) |
| PL (1) | PL3732293T3 (enExample) |
| PT (1) | PT3732293T (enExample) |
| WO (1) | WO2019129321A2 (enExample) |
| ZA (1) | ZA202003553B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4001417A1 (en) * | 2020-11-13 | 2022-05-25 | serYmun Yeast GmbH | Yeast platform for the production of vaccines |
| CN119391747B (zh) * | 2024-12-12 | 2025-11-18 | 华中农业大学 | 一种利用马克斯克鲁维酵母制备禽传染性法氏囊病vp2纳米颗粒口服疫苗的方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830463A (en) | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US7083787B2 (en) | 2000-11-15 | 2006-08-01 | Globeimmune, Inc. | Yeast-dendritic cell vaccines and uses thereof |
| CA2508957C (en) | 2002-12-16 | 2015-11-17 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| BRPI0516356A (pt) | 2004-10-18 | 2008-09-02 | Globeimmune Inc | terapia à base de levedura para infecções crÈnicas da hepatite c |
| SG169375A1 (en) | 2006-02-02 | 2011-03-30 | Globeimmune Inc | Yeast-based vaccine for inducing an immune response |
| DE102008057451A1 (de) | 2008-11-14 | 2010-05-20 | Martin-Luther-Universität Halle-Wittenberg | Verfahren zur oralen Vakzinierung mittels rekombinanter Hefen |
| KR101781966B1 (ko) | 2009-04-17 | 2017-09-27 | 글로브이뮨 | 암에 대한 병용 면역요법 조성물 및 방법 |
| DE102011121069A1 (de) | 2011-12-13 | 2013-06-13 | Martin-Luther-Universität Halle-Wittenberg | Vakzinierung mittels rekombinanter Hefe durch Erzeugung einer protektiven humoralen Immunantwort gegen definierte Antigene |
-
2017
- 2017-12-27 DE DE102017012109.5A patent/DE102017012109A1/de not_active Ceased
-
2018
- 2018-12-19 KR KR1020207021778A patent/KR102704217B1/ko active Active
- 2018-12-19 WO PCT/DE2018/000379 patent/WO2019129321A2/de not_active Ceased
- 2018-12-19 BR BR112020013245-4A patent/BR112020013245A2/pt unknown
- 2018-12-19 EP EP18857443.8A patent/EP3732293B1/de active Active
- 2018-12-19 JP JP2020555291A patent/JP7782951B2/ja active Active
- 2018-12-19 DK DK18857443.8T patent/DK3732293T3/da active
- 2018-12-19 DE DE112018006647.9T patent/DE112018006647A5/de not_active Withdrawn
- 2018-12-19 MX MX2020006846A patent/MX2020006846A/es unknown
- 2018-12-19 ES ES18857443T patent/ES2990197T3/es active Active
- 2018-12-19 PL PL18857443.8T patent/PL3732293T3/pl unknown
- 2018-12-19 CA CA3086598A patent/CA3086598A1/en active Pending
- 2018-12-19 HU HUE18857443A patent/HUE068358T2/hu unknown
- 2018-12-19 HR HRP20241297TT patent/HRP20241297T1/hr unknown
- 2018-12-19 CN CN201880083894.1A patent/CN111801422B/zh active Active
- 2018-12-19 US US16/958,170 patent/US11905517B2/en active Active
- 2018-12-19 PT PT188574438T patent/PT3732293T/pt unknown
- 2018-12-19 EA EA202091435A patent/EA202091435A1/ru unknown
-
2020
- 2020-06-12 ZA ZA2020/03553A patent/ZA202003553B/en unknown
-
2023
- 2023-08-16 JP JP2023132434A patent/JP2023166412A/ja active Pending
- 2023-10-05 US US18/481,345 patent/US12473562B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arnold et al. | Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit | |
| Noad et al. | Virus-like particles as immunogens | |
| CN1268747C (zh) | 重组的新城疫病毒rna表达系统及疫苗 | |
| Ramqvist et al. | Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer | |
| Liu et al. | Virus-like particles: potential veterinary vaccine immunogens | |
| Del Valle et al. | A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge | |
| JP2013533745A5 (enExample) | ||
| McCormick et al. | Genetically engineered Tobacco mosaic virus as nanoparticle vaccines | |
| US20190099477A1 (en) | Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (omvs) for delivery to the gi-tract | |
| Gedvilaite et al. | Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice | |
| Pascual et al. | Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity | |
| JP2004531232A (ja) | 高められた転写および複製能力をもつインフルエンザウイルス | |
| JP2019500320A5 (enExample) | ||
| JP2024009058A (ja) | ラッサワクチン | |
| Gupta et al. | Immunogenicity of next-generation HPV vaccines in non-human primates: measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine | |
| JP2021508496A5 (enExample) | ||
| Looi et al. | How far have we reached in development of effective influenza vaccine? | |
| WO2008035210A2 (en) | Recombinant hbsag virus-like particles containing polyepitopes of interest, their production and use | |
| Shoja et al. | Formation of self‐assembled triple‐layered rotavirus‐like particles (tlRLPs) by constitutive co‐expression of VP2, VP6, and VP7 in stably transfected high‐five insect cell lines | |
| JP2023166412A (ja) | 一価及び多価サブユニット予防ワクチン製造のために最適化した、酵母クルイベロマイセス・ラクティスベースの宿主／ベクターシステム | |
| CN104428417B (zh) | 利用针对确定抗原产生保护性体液免疫应答的重组酵母进行的接种 | |
| CN103451195A (zh) | 突变的噬菌体裂解基因e、含有该裂解基因的裂解质粒载体和在制备菌影疫苗中的应用 | |
| JP2009501012A5 (enExample) | ||
| JP2015507472A5 (enExample) | ||
| CN114729010B (zh) | 乙型肝炎病毒疫苗 |